Nkgen Biotech Inc (NKGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Sales | 0 | 0 | 77 | 0 | 0 |
| Cost of Goods | N/A | N/A | 18 | N/A | N/A |
| Gross Profit | N/A | N/A | 59 | N/A | N/A |
| Operating Expenses | 26,966 | 29,746 | 24,423 | 2,508 | 0 |
| Operating Income | -26,966 | -29,746 | -24,346 | -2,508 | N/A |
| Interest Expense | 2,724 | 745 | 2,306 | 0 | 0 |
| Other Income | -14,543 | -52,456 | -95 | 1,518 | 0 |
| Pre-tax Income | -44,233 | -82,947 | -26,747 | -991 | 0 |
| Income Tax | 53 | 7 | -7 | N/A | N/A |
| Net Income Continuous | -44,286 | -82,954 | -26,740 | -991 | N/A |
| Net Income | $-44,286 | $-82,954 | $-26,740 | $-991 | $N/A |
| EPS Basic Total Ops | -1.54 | -5.38 | -4.21 | -0.07 | N/A |
| EPS Basic Continuous Ops | -1.54 | -5.38 | -4.21 | -0.07 | N/A |
| EPS Diluted Total Ops | -1.54 | -5.38 | -4.21 | -0.07 | N/A |
| EPS Diluted Continuous Ops | -1.54 | -5.38 | -4.21 | -0.07 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.54 | -5.38 | N/A | N/A | N/A |
| EBITDA(a) | $-25,651 | $-28,543 | $-23,136 | $-2,508 | $N/A |